摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Tert-butyl-2-ethoxy-1,3,2lambda5-dioxaphospholane 2-oxide | 133191-35-2

中文名称
——
中文别名
——
英文名称
4-Tert-butyl-2-ethoxy-1,3,2lambda5-dioxaphospholane 2-oxide
英文别名
4-tert-butyl-2-ethoxy-1,3,2λ5-dioxaphospholane 2-oxide
4-Tert-butyl-2-ethoxy-1,3,2lambda5-dioxaphospholane 2-oxide化学式
CAS
133191-35-2;133191-36-3
化学式
C8H17O4P
mdl
——
分子量
208.194
InChiKey
HHNXPQJQEPZDCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    3,3-二甲基-1,2-环氧丁烷 、 endo-3-ethoxy-6-methyl-N-phenyl-2,3-oxaphosphabicyclo<2.2.2>oct-5-ene-8,9-dicarboxamide 3-oxide 以 甲苯 为溶剂, 以65%的产率得到4-Tert-butyl-2-ethoxy-1,3,2lambda5-dioxaphospholane 2-oxide
    参考文献:
    名称:
    Reaction of epoxides with metaphosphoric acid derivatives
    摘要:
    Ethyl metaphosphate (EtOPO2), eliminated in the thermolysis of the bridged cyclic phosphonate endo-3-ethoxy-6-methyl-N-phenyl-2,3-oxaphosphabicyclo[2.2.2]oct-5-ene-8,9-dicarboximide 3-oxide, has been found to cause ring opening of epoxides, resulting in formation of 2-ethoxy-4-substituted 1,3,2-dioxaphospholane 2-oxides as major products. N,N-Diethyl metaphosphoramidate (Et2NPO2) reacted similarly. With ethyl metathiophosphate (EtOP(S)O), the 1,3,2-oxathiaphospholane 2-oxide ring was formed. Products of these reactions were characterized by P-31 NMR spectroscopy and by GC-MS. These reactions are presumed to be initiated by electrophilic attack of the metaphosphate on the epoxide oxygen to form a cyclic oxonium ion.
    DOI:
    10.1021/jo00008a017
点击查看最新优质反应信息

文献信息

  • NSAIDs derivatives and uses thereof
    申请人:Research Foundation of The City University of New York
    公开号:US10023555B2
    公开(公告)日:2018-07-17
    The present invention discloses novel compounds derived from NSAIDs and pharmaceutically acceptable salts thereof. Other aspects of the invention relate to use of the NSAID derivatives in treating inflammatory diseases and pharmaceutical compositions thereof.
    本发明公开了源自非甾体抗炎药的新型化合物及其药学上可接受的盐类。本发明的其他方面涉及非甾体抗炎药衍生物在治疗炎症性疾病中的用途及其药物组合物。
  • Reaction of epoxides with metaphosphoric acid derivatives
    作者:Ryszard Bodalski、Louis D. Quin
    DOI:10.1021/jo00008a017
    日期:1991.4
    Ethyl metaphosphate (EtOPO2), eliminated in the thermolysis of the bridged cyclic phosphonate endo-3-ethoxy-6-methyl-N-phenyl-2,3-oxaphosphabicyclo[2.2.2]oct-5-ene-8,9-dicarboximide 3-oxide, has been found to cause ring opening of epoxides, resulting in formation of 2-ethoxy-4-substituted 1,3,2-dioxaphospholane 2-oxides as major products. N,N-Diethyl metaphosphoramidate (Et2NPO2) reacted similarly. With ethyl metathiophosphate (EtOP(S)O), the 1,3,2-oxathiaphospholane 2-oxide ring was formed. Products of these reactions were characterized by P-31 NMR spectroscopy and by GC-MS. These reactions are presumed to be initiated by electrophilic attack of the metaphosphate on the epoxide oxygen to form a cyclic oxonium ion.
查看更多

同类化合物

尿苷5'-二磷酸酯溴乙酰醇 N,N-二乙基-4-甲基-1,3,2-二氧杂磷杂环戊烷-2-胺 4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷-2-醇 2-氯-4-甲基-1,3,2-二氧杂磷杂环戊烷 2-氯-4,4,5,5-四甲基-1,3,2-二氧磷杂环戊烷 2-氯-1,3,2-二氧磷杂环戊烷 (3,5-二甲基苯基)[羟基(吡啶-4-基甲基)-lambda~5~-氮烷基]甲酮 2-(2-ethylbutoxy)-2-oxo-1,3,2-dioxaphospholane 2-(tert-butoxycarbonylamino)ethoxy-2-oxo-1,3,2-dioxaphospholane 5-dimethylamino-7-isopropylidene-8,8-dimethyl-1,4,6-trioxa-5λ5-phospha-spiro[4.4]nonan-9-one 5-dipropylaminomethyl-1,4,6,9-tetraoxa-5-phosphaspiro<4.4>nonane ethylenedioxy-O-(4,4-dimethyl-1,3-butadien-2-yl)phosphite pentamethyl-2,3,3,4,4 dioxaphospholane-1,3,2 propargyl ethylene phosphate 2-methylthio-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5-dioxaphospholane 2,2-bis(diethylamino)-2-(1,1,1,3,3,3-hexafluoro)isopropoxy-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5ς5-dioxaphospholane 4,4,5,5-tetrakis(trifluoromethyl)-2-<2,2,2-trifluoro-1-(trifluoromethyl)ethoxy>-spiro-<1,3,2λ5-dioxaphospholane-2,2'-(1,3,2λ5) dioxaphosphorinane> 4-chloromethyl-[1,3,2]dioxaphospholane 2-oxide 5-Methoxy-2,2,3,3-tetramethyl-7,9-bis(trifluoromethyl)-1,4,6-trioxa-5lambda5-phosphaspiro[4.4]non-7-en-9-ol 2,2-Dimethoxy-2-methyl-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2lambda5-dioxaphospholane 5,7-Dimethyl-2,2,3,3,9,9,10,10-octakis(trifluoromethyl)-1,4,6,8,11-pentaoxa-5lambda5,7lambda5-diphosphadispiro[4.1.47.35]tetradecane Butylamino-ethylendioxyphosphin 5-Dichloromethyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-Fluoro-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione Ethylendioxytributylphosphoran 2-Thiono-2-t-butyl-1,3,2-dioxaphospholan (5-TB-5-13;5'-TB-5-13)-2,2,3,3,2',2',3',3'-octamethyl-5,5'-ethane-1,2-diyldioxy-bis-(1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane) (1,4-Dioxa-6,9-dithia-5λ5-phospha-spiro[4.4]non-5-yl)-dimethyl-amine 5-Trimethylsilanylmethyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-Isopropyl-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane-2,7-dione 5-(2,2,2-Trifluoro-1-trifluoromethyl-ethoxy)-1,4,6,9-tetraoxa-5λ5-phospha-spiro[4.4]nonane 2,2,2-Tris-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane 2,2,2-trichloro-4,4-bis-chlorocarbonylmethyl-2λ5-[1,3,2]dioxaphospholan-5-one 5,6,7,12-Tetramethyl-2,2,3,3,9,9,10,10-octakis-trifluoromethyl-1,4,8,11-tetraoxa-6,12-diaza-5λ5,7λ5-diphospha-dispiro[4.1.4.1]dodecane 2,2-Difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-Fluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane (2-TB-5-12)-2-fluoro-4,4,5,5-tetrakis-trifluoromethyl-2,2-bis-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane Triethoxy-ethylendioxy-phosphoran 4,4,5,5-Tetrakis(trifluormethyl)-1,3,2λ5-dioxaphospholan-2,2,2-triamin 2-fluoro-4,4,5,5-tetrakis(trifluoromethyl)-1,3,2λ5-dioxaphospholane-2,2-diamine 2-Fluor-4,4,5,5-tetrakis-(trifluormethyl)-(1,3,2λ5-dioxaphospholan 5,7-difluoro-2,2,3,3,9,9,10,10-octakis-trifluoromethyl-6,12-bis-trimethylsilanyl-1,4,8,11-tetraoxa-6,12-diaza-5λ5,7λ5-diphospha-dispiro[4.1.4.1]dodecane [2-(1,1,1,3,3,3-hexamethyl-disilazan-2-yl)-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholan-2-ylidene]-trimethylsilanyl-amine 2,2-Di-tert-Butyl-2-chlor-4,4,5,5-tetrakis(trifluormethyl)-1,3,2λ5-dioxaphospholan 2-fluoro-2,2-dimethyl-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-fluoro-2,2-dimethyl-3,3,5,5-tetrakis-trifluoromethyl-2λ5-[1,4,2]dioxaphospholane 2-diethylamino-2,2-difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-diallylamino-2,2-difluoro-4,4,5,5-tetrakis-trifluoromethyl-2λ5-[1,3,2]dioxaphospholane 2-Methyl-4,4,5,5-tetrakis-trifluoromethyl-2,2-bis-(2,2,2-trifluoro-1-trifluoromethyl-ethoxy)-2λ5-[1,3,2]dioxaphospholane